International Biotechnology Trust Stock Debt To Equity
| IBT Stock | 694.00 8.00 1.17% |
International Biotechnology Trust fundamentals help investors to digest information that contributes to International Biotechnology's financial success or failures. It also enables traders to predict the movement of International Stock. The fundamental analysis module provides a way to measure International Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to International Biotechnology stock.
International | Debt To Equity |
International Biotechnology Trust Company Debt To Equity Analysis
International Biotechnology's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
International Total Stockholder Equity
Total Stockholder Equity |
|
According to the company disclosure, International Biotechnology Trust has a Debt To Equity of 0.0%. This is 100.0% lower than that of the Capital Markets sector and 100.0% lower than that of the Financials industry. The debt to equity for all United Kingdom stocks is 100.0% higher than that of the company.
Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
International Biotechnology ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, International Biotechnology's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to International Biotechnology's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
International Fundamentals
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0806 | |||
| Profit Margin | 0.91 % | |||
| Operating Margin | 1.00 % | |||
| Current Valuation | 268.03 M | |||
| Shares Outstanding | 36.29 M | |||
| Shares Owned By Insiders | 1.39 % | |||
| Shares Owned By Institutions | 44.41 % | |||
| Price To Book | 0.89 X | |||
| Price To Sales | 6.60 X | |||
| Revenue | 40.14 M | |||
| Gross Profit | (13.58 M) | |||
| EBITDA | 39.55 M | |||
| Net Income | 38.88 M | |||
| Total Debt | 22.83 M | |||
| Book Value Per Share | 7.66 X | |||
| Cash Flow From Operations | 45.35 M | |||
| Earnings Per Share | 1.02 X | |||
| Beta | 0.21 | |||
| Market Capitalization | 251.88 M | |||
| Total Asset | 308.15 M | |||
| Retained Earnings | (54.03 M) | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 308.15 M | |||
| Last Dividend Paid | 0.28 |
About International Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze International Biotechnology Trust's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of International Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of International Biotechnology Trust based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in International Stock
International Biotechnology financial ratios help investors to determine whether International Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in International with respect to the benefits of owning International Biotechnology security.